Koyfin Home > Directory > Health Care > Gilead Sciences Inc > Long-Term Debt / Capital

Gilead Sciences Inc Long-Term Debt / Capital Chart (GILD)

Gilead Sciences Inc annual/quarterly Long-Term Debt / Capital from 2010 to 2020.
  • Gilead Sciences Inc Long-Term Debt / Capital for the quarter ending June 06, 2020 was $50m a 1.25% increase of 1m year over year
  • Gilead Sciences Inc Long-Term Debt / Capital for the last 12 months ending June 06, 2020 was $50m a 1.25% increase of 1m year over year
  • Gilead Sciences Inc Annual Long-Term Debt / Capital for 2019 was $47m a -6.19% decrease of -3m from 2018
  • Gilead Sciences Inc Annual Long-Term Debt / Capital for 2018 was $50m a -13.29% decrease of -7m from 2017
  • Gilead Sciences Inc Annual Long-Term Debt / Capital for 2017 was $57m a -1.15% decrease of -1m from 2016
Other Ratios Metrics:
  • Gilead Sciences Inc Total Debt / Capital for the quarter ending December 12, 2018 was $59m a 1.63% increase of 1m year over year
  • Gilead Sciences Inc Other Liabilities for the quarter ending September 09, 2018 was $6,612m a -11.19% decrease of -740m year over year
  • Gilead Sciences Inc Total Debt / Equity for the quarter ending December 12, 2018 was $146m a 3.93% increase of 6m year over year
View Chart On Koyfin

Quarterly GILD Long-Term Debt / Capital Data

06/2020$50m
03/2020$48m
12/2019$47m
09/2019$49m
06/2019$50m
03/2019$50m
12/2018$50m
09/2018$49m
06/2018$51m
03/2018$53m

Annual GILD Long-Term Debt / Capital Data

2019$47m
2018$50m
2017$57m
2016$58m
2015$51m
2014$42m
2013$21m
2012$40m
2011$53m
2010$30m